These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10686300

  • 1. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat.
    Nijsen MJ, Croiset G, Diamant M, Stam R, Kamphuis PJ, Bruijnzeel A, de Wied D, Wiegant VM.
    Eur J Pharmacol; 2000 Feb 11; 389(1):89-98. PubMed ID: 10686300
    [Abstract] [Full Text] [Related]

  • 2. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats.
    Nijsen MJ, Croiset G, Diamant M, De Wied D, Wiegant VM.
    Neuropsychopharmacology; 2001 Jan 11; 24(1):1-10. PubMed ID: 11106870
    [Abstract] [Full Text] [Related]

  • 3. Conditioned fear-induced tachycardia in the rat: vagal involvement.
    Nijsen MJ, Croiset G, Diamant M, Stam R, Delsing D, de Wied D, Wiegant VM.
    Eur J Pharmacol; 1998 Jun 05; 350(2-3):211-22. PubMed ID: 9696410
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing hormone microinfusion in the central amygdala diminishes a cardiac parasympathetic outflow under stress-free conditions.
    Wiersma A, Bohus B, Koolhaas JM.
    Brain Res; 1993 Oct 22; 625(2):219-27. PubMed ID: 8275304
    [Abstract] [Full Text] [Related]

  • 5. The role of the CRH type 1 receptor in autonomic responses to corticotropin- releasing hormone in the rat.
    Nijsen MJ, Croiset G, Stam R, Bruijnzeel A, Diamant M, de Wied D, Wiegant VM.
    Neuropsychopharmacology; 2000 Apr 22; 22(4):388-99. PubMed ID: 10700658
    [Abstract] [Full Text] [Related]

  • 6. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems.
    Kalin NH, Takahashi LK.
    Brain Res; 1990 Feb 12; 509(1):80-4. PubMed ID: 2155045
    [Abstract] [Full Text] [Related]

  • 7. Possible regulatory mechanism of DHA-induced anti-stress reaction in rats.
    Takeuchi T, Iwanaga M, Harada E.
    Brain Res; 2003 Feb 21; 964(1):136-43. PubMed ID: 12573522
    [Abstract] [Full Text] [Related]

  • 8. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW.
    Endocrinology; 1999 Jan 21; 140(1):79-86. PubMed ID: 9886810
    [Abstract] [Full Text] [Related]

  • 9. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement.
    Korte SM, Bouws GA, Bohus B.
    Horm Behav; 1993 Jun 21; 27(2):167-83. PubMed ID: 8394279
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats.
    Kalin NH, Sherman JE, Takahashi LK.
    Brain Res; 1988 Aug 02; 457(1):130-5. PubMed ID: 3262400
    [Abstract] [Full Text] [Related]

  • 11. Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.
    Jahn H, Montkowski A, Knaudt K, Ströhle A, Kiefer F, Schick M, Wiedemann K.
    Brain Res; 2001 Mar 02; 893(1-2):21-8. PubMed ID: 11222988
    [Abstract] [Full Text] [Related]

  • 12. The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures.
    Skórzewska A, Bidziński A, Hamed A, Lehner M, Turzyńska D, Sobolewska A, Maciejak P, Szyndler J, Wisłowska-Stanek A, Płaźnik A.
    Horm Behav; 2008 Nov 02; 54(5):602-12. PubMed ID: 18601929
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses.
    Perez L, Lysle DT.
    J Neuroimmunol; 1995 Dec 02; 63(1):1-8. PubMed ID: 8557820
    [Abstract] [Full Text] [Related]

  • 14. Role of brain thromboxane A2 in the release of noradrenaline and adrenaline from adrenal medulla in rats.
    Okada S, Murakami Y, Yokotani K.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):125-31. PubMed ID: 12706465
    [Abstract] [Full Text] [Related]

  • 15. Salivary alpha-amylase and noradrenaline responses to corticotropin-releasing hormone administration in humans.
    Petrakova L, Boy K, Mittmann L, Möller L, Engler H, Schedlowski M.
    Biol Psychol; 2017 Jul 25; 127():34-39. PubMed ID: 28472693
    [Abstract] [Full Text] [Related]

  • 16. Role of CRH in glucopenia-induced adrenomedullary activation in rats.
    Goldstein DS, Garty M, Bagdy G, Szemeredi K, Sternberg EM, Listwak S, Pacak K, Deka-Starosta A, Hoffman A, Chang PC.
    J Neuroendocrinol; 1993 Oct 25; 5(5):475-86. PubMed ID: 8680414
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O, Meyer M, Jahn O, Ogren SO, Spiess J.
    J Pharmacol Exp Ther; 2005 Mar 25; 312(3):905-16. PubMed ID: 15537825
    [Abstract] [Full Text] [Related]

  • 18. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
    Skórzewska A, Lehner M, Hamed A, Wisłowska-Stanek A, Turzyńska D, Sobolewska A, Płaźnik A.
    Behav Brain Res; 2011 Aug 01; 221(1):155-65. PubMed ID: 21376756
    [Abstract] [Full Text] [Related]

  • 19. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
    de Jongh R, Groenink L, van der Gugten J, Olivier B.
    Biol Psychiatry; 2003 Nov 15; 54(10):1041-8. PubMed ID: 14625146
    [Abstract] [Full Text] [Related]

  • 20. Inducible nitric oxide synthase is involved in corticotropin-releasing hormone-mediated central sympatho-adrenal outflow in rats.
    Okada S, Yokotani K, Yokotani K.
    Eur J Pharmacol; 2003 Sep 12; 477(2):95-100. PubMed ID: 14519412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.